Skip to main
TBPH

TBPH Market Capitalization Overview

Market Cap: $883.71M as of Oct 2, 2026

$883.71M
$3.07M (0.35%)past month
As of Oct 2, 2026, TBPH has a market capitalization of $883.71M. Over the past 30 days, its market cap has increased by 0%, while in the last 12 months, it has decreased by -6.79%.

Market capitalization represents the total value of Theravance Biopharma Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

TBPH Market Cap Formula = Stock Price * Shares Outstanding

The market cap of TBPH helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

TBPH Market Cap History

DateMarket CapChange
Oct 1, 2026$884.18M0.00%
Sep 1, 2026$884.18M+1.12%
Aug 3, 2026$874.35M-0.12%
Jul 1, 2026$875.37M+6.52%
Jun 1, 2026$821.76M-4.95%
May 1, 2026$864.57M+6.00%
Apr 1, 2026$815.65M-15.06%
Mar 2, 2026$960.25M-4.44%
Feb 2, 2026$1.01B+9.26%
Jan 2, 2026$919.71M-7.45%

TBPH End of Year Market Cap History

DateMarket CapChange
2026$883.71M-6.79%
2025$948.09M+104.89%
2024$462.74M-17.33%
2023$559.73M-25.95%
2022$755.85M-7.19%
2021$814.37M—

FAQs About Theravance Biopharma Inc (TBPH) Market Cap

As of Oct 2, 2026, the market capitalization of TBPH is $883.71M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Theravance Biopharma Inc’s market capitalization has decreased by -0.3500%, changing from $886.78M to $883.71M as of Oct 2, 2026.

In the last 3 months, Theravance Biopharma Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Theravance Biopharma Inc’s market capitalization increased from $462.74M in January to $948.09M in December, reflecting a 104.89% change.

In the past five years, TBPH has had a compound annual growth rate (CAGR) of 3.09% in market capitalization. This means its market cap has grown at an average rate of 3.09% per year.

Theravance Biopharma Inc (TBPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.